Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Cancers|April 5, 2020
The Multifactorial Role of PARP-1 in Tumor MicroenvironmentJuan Manuel Martí, Mónica Fernández-Cortés, Santiago Serrano-Sáenz, et al.
The Oncologist|July 29, 2020
AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving AnalysisRafael Adrián Pacheco-Orozco, Lorena Montealegre-Páez, Federico Cayol, et al.
Scientific Reports|April 15, 2020
Crosstalk between hydroxytyrosol, a major olive oil phenol, and HIF-1 in MCF-7 breast cancer cellsJesús Calahorra, Esther Martínez-Lara, José M Granadino-Roldán, et al.
Medicinal Research Reviews|January 22, 2015
Deciphering the insights of poly(ADP-ribosylation) in tumor progressionMaría Isabel Rodríguez, Jara Majuelos-Melguizo, Juan Manuel Martí Martín-Consuegra, et al.
Cancers|December 30, 2025
Targeting MARylation and DePARylation in Cancer Therapy: New Promising Therapeutic OpportunitiesVanesa Cabeza-Fernández, Francisco Javier Ríos-Sola, David Martín-Oliva, et al.
Cancers|June 10, 2022
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune SystemAna Belén Herrera-Campos, Esteban Zamudio-Martinez, Daniel Delgado-Bellido, et al.
Cancer Letters|September 19, 2013
Direct and bystander radiation effects: a biophysical model and clinical perspectivesPedro Carlos Lara, Jesús Joaquín López-Peñalver, Virgínea de Araújo Farias, et al.
The Journal of Rheumatology|November 3, 2005
Association of a functional inducible nitric oxide synthase promoter variant with susceptibility to biopsy-proven giant cell arteritisMiguel A Gonzalez-Gay, Javier Oliver, Elena Sanchez, et al.
Free Radical Biology & Medicine|April 14, 2009
PARP inhibitors: new partners in the therapy of cancer and inflammatory diseasesAndreína Peralta-Leal, José Manuel Rodríguez-Vargas, Rocío Aguilar-Quesada, et al.
Plos One|October 14, 2015
Functional Consequences for Apoptosis by Transcription Elongation Regulator 1 (TCERG1)-Mediated Bcl-x and Fas/CD95 Alternative SplicingMarta Montes, Mayte Coiras, Soraya Becerra, et al.
Pageof 10